Parenteral Drug Association
Connecting People, Science and Regulation ®
Rebecca Stauffer, PDA
Robert A. Schaut, PhD, and W. Porter Weeks, Corning Incorporated
Roy Cherris, Bridge Associates International
Ursula Busse, PhD, Novartis, and Steffen Gross, Paul-Ehrlich-Institut
Mathias Romacker, Pfizer, and Hanns-Christian Mahler, Lonza
Kathleen Souza, MilliporeSigma
Nrupa Patel, Teligent Pharma Inc., and Sandip Patel, Navinta LLC
Wendy Saffell-Clemmer, Baxter Healthcare
Anders Vinther, Sanofi Pasteur; Emma Ramnarine, Genentech; co-chairs PDA Post Approval Change: Innovation for Availability of Medicines (PAC iAM) Task Force
Stefan Kleinmann, PhD, METALL+PLASTIC, Matthias Scheu, METALL+PLASTIC, Roland Schuhwerk, Cilag AG, and Volker Baur, Cilag AG
Susan Schniepp, Regulatory Compliance Associates, and Steven Mendivil, Amgen
Toni Manzano, bigfinite
Egmont Semmler, Groninger & Co.
John Shabushnig, PhD, Insight Pharma Consulting, and Markus Lankers, PhD, rap.ID Particle Systems GmbH
PDA Japan Chapter Annual Meeting Committee
Brittany Cloud, Eurofins Lancaster Laboratories, Inc.